Evidence map›Paper›PMID 39328734›Full record

ArticleIndian journal of surgical oncology2024

Giant Renal Angiomyolipoma: A Rare and Formidable Challenge: A Case Report.

Bhoopendra Singh Gora, Suresh Singh, Agil Babu, Kamal Kishor Lakhera, Pinakin Patel, Pranav M Singhal, Naina Kumar, Mahesh Diama

Abstract readCase Reports
In one paragraph

Article in Indian journal of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bhoopendra Singh GoraDepartment of Surgical Oncology, SMS Medical College and Attached Hospitals, Jaipur, Rajasthan India 302004.
Suresh SinghDepartment of Surgical Oncology, SMS Medical College and Attached Hospitals, Jaipur, Rajasthan India 302004.
Agil BabuDepartment of Surgical Oncology, SMS Medical College and Attached Hospitals, Jaipur, Rajasthan India 302004.ORCID 0000-0003-2697-9782
Kamal Kishor LakheraDepartment of Surgical Oncology, SMS Medical College and Attached Hospitals, Jaipur, Rajasthan India 302004.
Pinakin PatelDepartment of Surgical Oncology, SMS Medical College and Attached Hospitals, Jaipur, Rajasthan India 302004.
Pranav M SinghalDepartment of Surgical Oncology, SMS Medical College and Attached Hospitals, Jaipur, Rajasthan India 302004.
Naina KumarDepartment of Surgical Oncology, SMS Medical College and Attached Hospitals, Jaipur, Rajasthan India 302004.
Mahesh DiamaDepartment of Surgical Oncology, SMS Medical College and Attached Hospitals, Jaipur, Rajasthan India 302004.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal angiomyolipoma (AML), also referred to as renal hamartoma, is a rare solid tumor without malignant characteristics. The inheritance pattern of renal AML is autosomal dominant. If the lesion grows to a large size, a series of clinical manifestations and serious complications may occur. We herein present a case of giant renal AML in a 49-year-old female patient, who presented with left-sided abdominal bloating for 1 month. Following abdominal ultrasound and computed tomography examination, the patient underwent total left nephrectomy. The resected mass was sized 18 × 15 × 11 cm. Postoperative histopathological examination confirmed the lesion as a giant renal AML. There are only few cases of giant renal AML (> 10 cm) reported in the literature to date. Due to the large size of the tumor, it is crucial to report similar cases, their diagnosis, and treatment.

Indexed as

Giant kidney tumorHamartomasNephrectomyRenal angiomyolipomaRenal tumor

Identifiers

PMID39328734
PMCPMC11422309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.